deltatrials
Completed PHASE1 NCT00006372

Combination Chemotherapy in Treating Patients With Advanced Solid Tumors

Phase I Trial of Combination Pegylated Liposomal Doxorubicin (Doxil), Vinorelbine, and Gemcitabine

Sponsor: Case Comprehensive Cancer Center

Conditions Unspecified Adult Solid Tumor, Protocol Specific
Interventions gemcitabine hydrochloride pegylated liposomal doxorubicin hydrochloride vinorelbine ditartrate
Updated 5 times since 2017 Last updated: Jun 9, 2010 Started: Feb 29, 2000 Primary completion: Apr 30, 2003 Completion: Feb 28, 2005

This PHASE1 trial investigates Unspecified Adult Solid Tumor, Protocol Specific and is currently completed. Case Comprehensive Cancer Center leads this study, which shows 5 recorded versions since 2000 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

Feb 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Case Comprehensive Cancer Center
  • National Cancer Institute (NCI)
Data source: Case Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Cleveland, United States